EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Galectins and Liver Diseases

Shima Mimura iD, Asahiro Morishita iD, Kyoko Oura iD, Kei Takuma iD, Mai Nakahara iD, Tomoko Tadokoro iD, Koji Fujita, Joji Tani, Hideki Kobara

International Journal of Molecular Sciences · 18.01.2025 · 26 (2) · 790

DOI: 10.3390/ijms26020790 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.01.2025. Verfasst von Shima Mimura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun, Takamatsu 761-0793, Kagawa Prefecture, Japan. Hauptthemen laut MEDLINE: Galectins, Liver Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Galectins are widely distributed throughout the animal kingdom, from marine sponges to mammals. Galectins are a family of soluble lectins that specifically recognize β-galactoside-containing glycans and are categorized into three subgroups based on the number and function of their carbohydrate recognition domains (CRDs). The interaction of galectins with specific ligands mediates a wide range of biological activities, depending on the cell type, tissue context, expression levels of individual galectin, and receptor involvement. Galectins affect various immune cell processes through both intracellular and extracellular mechanisms and play roles in processes, such as apoptosis, angiogenesis, and fibrosis. Their importance has increased in recent years because they are recognized as biomarkers, therapeutic agents, and drug targets, with many other applications in conditions such as cardiovascular diseases and cancer. However, little is known about the involvement of galectins in liver diseases. Here, we review the functions of various galectins and evaluate their roles in liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalectinsLiver DiseasesHumansAnimals

Stichwörter der Autor:innen

angiogenesisapoptosisbiomarkerfibrosisgalectingut–liver axishepatocellular carcinomaimmune response

Substanzen

Galectins

Autor:innen und Institutionen

  • Departments of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun, Takamatsu 761-0793, Kagawa Prefecture, Japan.

ORCID-Profile: Shima Mimura, Asahiro Morishita, Kyoko Oura, Kei Takuma, Mai Nakahara, Tomoko Tadokoro

Zitieren

APA

Mimura, S., Morishita, A., Oura, K., Takuma, K., Nakahara, M., Tadokoro, T., Fujita, K., Tani, J., & Kobara, H. (2025). Galectins and Liver Diseases. International Journal of Molecular Sciences, 26(2), 790. https://doi.org/10.3390/ijms26020790

Vancouver

Mimura S, Morishita A, Oura K, Takuma K, Nakahara M, Tadokoro T, et al. Galectins and Liver Diseases. International Journal of Molecular Sciences. 2025;26(2):790. doi:10.3390/ijms26020790

BibTeX
@article{Mimura2025,
  author = {Mimura, Shima and Morishita, Asahiro and Oura, Kyoko and Takuma, Kei and Nakahara, Mai and Tadokoro, Tomoko and Fujita, Koji and Tani, Joji and Kobara, Hideki},
  title = {Galectins and Liver Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {2},
  pages = {790},
  doi = {10.3390/ijms26020790}
}
Kostenlos starten →